Literature DB >> 3346945

Transformed and tumorigenic phenotypes induced by avian retroviruses containing the v-mil oncogene.

C Béchade1, G Dambrine, T David-Pfeuty, E Esnault, G Calothy.   

Abstract

Avian retrovirus MH2 contains two oncogenes, v-mil and v-myc. We have previously shown that a spontaneous mutant of MH2 (PA200-MH2), expressing only the v-mil oncogene, is able to induce proliferation of quiescent neuroretina cells. In this study, we investigated the transforming and tumorigenic properties of v-mil. PA200 induced fibrosarcomas in about 60% of the injected chickens, whereas inoculation of MH2 resulted mainly in the appearance of kidney carcinomas. Analysis of several parameters of transformation showed that PA200, in contrast to MH2, induced only limited in vitro transformation of fibroblasts and neuroretina cells. These results suggest that v-myc is the major transforming and tumorigenic gene in MH2-infected cells. This low in vitro transforming capacity differentiates v-mil not only from other avian oncogenes, but also from the homologous murine v-raf gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346945      PMCID: PMC253129     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Nucleotide sequence analysis of the chicken gene c-mil, the progenitor of the retroviral oncogene v-mil.

Authors:  H W Jansen; K Bister
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

4.  Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins.

Authors:  K Moelling; B Heimann; P Beimling; U R Rapp; T Sander
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

5.  Structural relationship between the chicken protooncogene c-mil and the retroviral oncogene v-mil.

Authors:  H W Jansen; C Trachmann; K Bister
Journal:  Virology       Date:  1984-08       Impact factor: 3.616

6.  Autocrine growth induced by src-related oncogenes in transformed chicken myeloid cells.

Authors:  B Adkins; A Leutz; T Graf
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus.

Authors:  U R Rapp; J L Cleveland; T N Fredrickson; K L Holmes; H C Morse; H W Jansen; T Patschinsky; K Bister
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

8.  Mutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblasts.

Authors:  R P Zhou; N Kan; T Papas; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.

Authors:  U R Rapp; M D Goldsborough; G E Mark; T I Bonner; J Groffen; F H Reynolds; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic.

Authors:  S Palmieri; P Kahn; T Graf
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  2 in total

Review 1.  Mammalian neural stem-cell renewal: nature versus nurture.

Authors:  Yvan Arsenijevic
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

2.  Molecular and biological properties of c-mil transducing retroviruses generated during passage of Rous-associated virus type 1 in chicken neuroretina cells.

Authors:  A Eychène; C Béchade; M Marx; D Laugier; P Dezélée; G Calothy
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.